Navigation Links
Starch Medical Launches Novel Plant Sourced Surgical Hemostatic Pad
Date:10/20/2009

SAN JOSE, Calif., Oct. 20 /PRNewswire/ -- Starch Medical Inc (SMI), a San Jose, CA-based medical device manufacturer, announces the first controlled clinical intro/launch of SealFoam(TM) Absorbable Polysaccharide Hemostat in the European Union and other major international markets. Introduction of SealFoam(TM) Absorbable Polysaccharide Hemostat will commence this month at the European Association of Cardio-Thoracic Surgeons congress in Vienna and in November at the MEDICA congress in Dusseldorf, Germany (booth #16E20).

SealFoam(TM) is the latest addition to the Absorbable Modified Polymer (AMP(TM)) product line and offers a hemostatic foam (pad) configuration for a wide range of surgical wounds. The ultra hydrophilic and adhesive properties of SealFoam(TM) are especially formulated to control oozing or profuse bleeding, and to minimize the possibility of re-bleeding. The pad may also be trimmed to suit the surgical procedure and is indicated for a diverse range of applications and unique wound contours.

AMP(TM) technology is a proprietary engineering process that modifies plant starch into biocompatible, absorbable, hemostatic polysaccharide particles. AMP(TM) particles have a molecular structure that rapidly absorbs water from blood, causing a high concentration of platelets, red blood cells and coagulation proteins which accelerate the physiologic clotting cascade at the bleeding site.

David Lang, President of SMI, states "SealFoam(TM) is currently the only available surgical hemostatic pad derived from plant starch without animal/human components. The superb efficacy offers surgeons a safe alternative for achieving hemostasis under various surgical conditions. We will introduce SealFoam(TM) through our global distribution network and potential partners during the 4th quarter of this year."

SMI is a privately-held medical device company engaged in the design, manufacture, marketing and licensing of breakthrough, hemostatic solutions. Starch Medical's proprietary, patent-pending technology platform (AMP(TM)), including powders, foams and films, will focus on the worldwide, multi-billion dollar biomaterial, hemostasis, and wound care marketplace.

For additional information, distribution inquiries, and licensing options, please visit www.starchmedical.com.

Contact: Jane Chen of Starch Medical Inc, +1-408-428-9818, jane@starchmedical.com

SOURCE Starch Medical Inc


'/>"/>
SOURCE Starch Medical Inc
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 ... from continuing operations Second-quarter ... $110 million Second-quarter 2017 ... Second-quarter 2017 adjusted diluted ... percent to $0.93 Second-quarter ...
(Date:8/7/2017)... Aug. 7, 2017  Endo International plc (NASDAQ: ... to resolve virtually all known U.S. mesh product liability ... resolve the known remaining U.S. claims at reasonable values. ... in the fourth quarter of 2017 and continuing through ... second quarter 2017 results, the Company intends to increase ...
(Date:8/2/2017)... BENTON, Ky. , Aug. 2, 2017   Marshall County Hospital in ... (ES) team to proactively reduce the risk of hospital-acquired infections (HAIs). The new addition, ... uses UVC light energy to kill deadly pathogens such as C. diff , MRSA, ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
Breaking Medicine Technology:
(Date:8/19/2017)... ... August 19, 2017 , ... Parker at Stonegate, ... over 1,000 passionate employees, caregivers, volunteers, thought leaders, researchers, educators and partners leading ... it was time to refresh the carpeting with the goal of maintaining the ...
(Date:8/18/2017)... ... ... More than 20,000 pairs of shoes made their way across the Atlantic ... that conjoined the passions of an NBA star, a Liberty University student, and an ... will save lives from the rampant infections transmitted through the soil. , AMERICAN SOLES ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... edition of “Vision & Hearing,” advocating for active, healthy lifestyles and highlighting the ... available for individuals with hearing impairments and shares the latest innovations in hearing ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... services and financial consultations to communities throughout the greater DC region, is inaugurating ... the goal of rescuing local animals and training them to be companions for ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Brian Gifford Agency, an Indiana-based ... campaigning in support of Campagna Academy in a charity drive to provide for at-risk ... Town of Indiana,” Campagna Academy is a nonprofit organization that has offered critical programs ...
Breaking Medicine News(10 mins):